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Prolactin (PRL) is essential for the maintenance of the corpora lutea and the production of progesterone (P4) during gestation of
mice and rats, which makes it a key factor for their successful reproduction. Unlike these rodents and the vast majority of mammals,
female vizcachas (Lagostomus maximus) have a peculiar reproductive biology characterized by an ovulatory event during
pregnancy that generates secondary corpora lutea with a consequent increment of the circulating P4. We found that, although
the expression of pituitary PRL increased steadily during pregnancy, its ovarian receptor (PRLR) reached its maximum in
midpregnancy and drastically decreased at term pregnancy. The luteinizing hormone receptor (LHR) exhibited a similar proﬁle
than PRLR. Maximum P4 and LH blood levels were recorded at midpregnancy as well. Remarkably, the P4-sinthesizing enzyme
3β-HSD accompanied the expression pattern of PRLR/LHR throughout gestation. Instead, the luteolytic enzyme 20α-HSD
showed low expression at early and midpregnancy, but reached its maximum at the end of gestation, when PRLR/LHR/3ß-HSD
expressions and circulating P4 were minimal. In conclusion, both the PRLR and LHR expressions in the ovary would deﬁne the
success of gestation in vizcachas by modulating the levels of 20α-HSD and 3ß-HSD, which ultimately determine the level of
serum P4 throughout gestation.
1. Introduction
The corpus luteum (CL) is a transient endocrine gland that
biosynthesizes steroids under the control of luteotropic fac-
tors. The CL synthesizes large amounts of progesterone
(P4), which has an important role in the modulation of the
estrous cycle and in the maintenance of pregnancy as well
as an intermediary role in the synthesis of corticosteroids
and androgens ([1–3] for a review). In mice and rats, the
corpora lutea are the main source of P4 that will support
the gestation process. In fact, mouse models in which the
P4 receptor (PR) has been ablated are infertile and display
reproductive abnormalities as embryo implantation failure,
defects in uterine decidualization, and an abnormal response
to estradiol, thus demonstrating how critical P4 is for the
normal progress of pregnancy [4–6]. P4 exerts its action via
the PR, a member of the nuclear receptor superfamily of
transcription factors. Upon ligand binding, the PR dimerizes
and binds to PR response elements in the promoters of its
target genes such as bone morphogenetic protein 2 (Bmp2),
homeobox A10 (Hoxa10), and Indian hedgehog (Ihh), all
molecules whose important actions during gestation have
already been widely established ([7], for a review).
The CL expresses key proteins and steroidogenic
enzymes involved in the uptake, synthesis, and transport of
cholesterol and in the processing of cholesterol to P4. The
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ﬁrst step in the path of P4 biosynthesis is performed by the
cytochrome P450 side-chain cleavage (P450scc), which con-
verts cholesterol into pregnenolone. In turn, pregnenolone
is converted into the active metabolite, P4, by the action of
the oxidoreductase enzyme 3ß-hydroxysteroid dehydroge-
nase/Δ5-Δ4 isomerase (3β-HSD) [8]. P4 production is tied
to the expression level of these two enzymes. In fact, Richards
and coworkers have documented a signiﬁcant increase both
in P450scc and 3β-HSD transcript levels in luteal cells during
the luteinization process [9, 10].
On the contrary, 20α-hydroxysteroid dehydrogenase
(20α-HSD) catalyzes the reduction of P4, leading to the for-
mation of the progestationally inactive steroid, 20α-hydroxy-
pregn-4-en-3-one (20α-hydroxyprogesterone). This enzyme
also belongs to the family of oxidoreductases, and it has
shown to play a signiﬁcant role in luteolysis and parturition.
While luteal 20α-HSD expression and activity are downregu-
lated in mice and rats, 24 h prior to parturition ovarian 20α-
HSD activity is acutely stimulated. Such stimulation is man-
datory for the ﬁnal reduction of P4 blood levels preceding
parturition [11–16]. These two enzymes that participate in
the metabolism of P4 are targets of tropic hormones such
as prolactin (PRL) and luteinizing hormone (LH), as well as
of endogenous and circulating steroids [3, 17].
Prolactin (PRL) is a 23 kDa protein mainly secreted by
lactotropic cells of the anterior pituitary gland, and it has
been originally identiﬁed by its stimulatory action on mam-
mary glands during pregnancy and lactation. However, it is
now known that besides the mammary glands, PRL targets
several other tissues expressing its membrane-bound recep-
tor (PRLR) and modulates a great variety of biological func-
tions ([18] for a review). Focusing on the implications of PRL
actions over the reproductive process, it has been shown in
transgenic mice models that ablation of either PRL or PRLR
gene greatly impairs female fertility [19, 20]. The lack of
PRL signaling leads to the impossibility of maintaining the
implantation of the embryo mainly due to an insuﬃcient
production of luteal P4. Two days after mating, PRLR knock-
out ovaries exhibit corpora lutea undergoing regression and
an impairment in steroidogenesis [21]. This clearly estab-
lishes the critical role of PRL in the maintenance of the CL
and production of P4 for rodent reproduction ([2, 3, 22, 23]
for a review).
The South American plains vizcacha, Lagostomus max-
imus (Rodentia: Chinchillidae), is a hystricognathe fosso-
rial rodent that inhabits the Pampas region of Argentina
extending up to the South of Paraguay and Bolivia [24].
Over forty years ago, Barbara Weir described particular
aspects of the reproductive biology of female vizcachas
that highlight this species among the majority of mammals
[25, 26]. The ovaries of adult specimens exhibit natural
massive polyovulation that can go up to 800 oocytes per
cycle, the highest ovulatory rate so far recorded for a
mammal. Although the oocytes are ovulated literally in
hundreds, just 10 to 12 of them will be eventually fertil-
ized and implanted, but only those two implanted nearest
the cervix will complete their embryonic development
[26, 27]. An unusual long gestation is also a distinctive trait
of vizcachas. Its 5-month length pregnancy is considered a
long period for a rodent, and it is one of the longest recorded
among hystricomorphs [25].
But what undoubtedly is the most outstanding aspect of
its reproductive proﬁle is the atypical gestational hormonal
pattern characterized by the release of gonadotropin-
releasing hormone (GnRH) followed by an LH surge around
day 110 of gestation. This rise in LH leads to an ovulatory
event that produces a great number of secondary corpora
lutea with oocyte retention (i.e., pseudoovulation) and a con-
sequent and marked increment of the P4 levels [28–31]. This
uncommon boost up in the circulating P4 may contribute to
the accurate maintenance of the uterus and embryo develop-
ment up to the end of a long gestation [28, 32]. Since PRL has
shown to be essential for synthesis and secretion of luteal P4
during pregnancy in both mice and rats, we hypothesized
that PRL also plays a role in the luteal steroidogenesis in
pregnant vizcachas. For that, we examined ovarian PRLR
expression as well as that of several P4 production-
modulating molecules and we found a consistent expression
pattern along gestation for ovarian PRLR/LHR/3β-HSD that
contrasts with that of 20α-HSD, pinpointing PRL and LH as
central players in the modulation of luteal steroidogenesis
and P4 production in pregnant vizcachas.
2. Material and Methods
2.1. Animal Handling. Twenty-ﬁve female vizcachas, L. max-
imus, weighting between 1.9 and 2.5 kg were used throughout
the present study. Animals were captured in their habitat
using live traps placed in their burrows in a natural popula-
tion site at the Estación de Cría de Animales Silvestres
(ECAS), Province of Buenos Aires, Argentina (34° 51′ 0″ S,
58° 6′ 37″ W). The capture and transport of animals were
approved by the Ministry of Agriculture Authority of the
Buenos Aires Province Government. Animals were housed
for one week before euthanasia, under a 12 : 12 h light cycle
to simulate their natural luminal exposure (low light of 12
watts followed by moon light) and 22± 2°C room tempera-
ture, with ad libitum access to food and tap water.
Animals were grouped according to their reproductive
status as the following: early pregnancy (EP), midpregnancy
(MP), and term pregnancy (TP), lactating nonpregnant
(LCT) and non-ovulating non-pregnant (NP) females
(Table 1). In order to establish the diﬀerent groups, the time
of capture was carefully planned according to the natural
reproductive cycle of the vizcachas previously described by
Llanos and Crespo [33] and also based on our own ﬁeld
expertise [28–32, 34–36]. Pregnant vizcachas were captured
during the breeding season that lasts from April to August.
Gestational stage was estimated by the time of capture and
conﬁrmed during the surgical procedure by the degree of fetal
development as previously described [32, 37]. The midpreg-
nant group was formed with pregnant individuals whose
ovaries exhibited, at the time of sacriﬁce, ovulatory stigmatas
as evidence of a recent ovulatory event and later conﬁrmed
for the presence of secondary corpora lutea in hematoxylin-
eosin stained ovary sections. Nonpregnant females were
captured in mid-September after the end of the reproductive
season. Lactating female group (LCT) was established by
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selecting those nonpregnant animals whosemammary glands
exhibited the histological features already described for this
period [29, 38] (Table 1).
2.2. Animal Surgery and Tissue Sample Collection. Animal
surgery was performed as previously described in Inserra
et al. [36]. Brieﬂy, animals were anesthetized with ketamine
chlorhydrate 13.5mg/kg body weight (Holliday Scott S.A.,
Buenos Aires, Argentina) and xilacine clorhydrate 0.6mg/
kg body weight (Laboratorios Richmond, Buenos Aires,
Argentina). Blood samples taken by puncture of the inferior
vena cava were centrifuged at 3000 rpm for 15min, and the
serum was separated, aliquoted, and stored at −20°C for the
subsequent hormonal assays. After bleeding, animals were
sacriﬁced by an intracardiac injection of Euthanyle 0.5ml/
kg body weight (sodic pentobarbital, sodic diphenyl hydan-
toinate; Brouwer S.A., Buenos Aires, Argentina). Pituitaries
and ovaries were surgically removed and either stored at
−80°C for subsequent PCR studies or ﬁxed for 48h in cold
4% paraformaldehyde (PFA) in 0.01M phosphate-buﬀered
saline (PBS, pH7.4) for histological studies.
All experimental protocols performed in the present
study were reviewed and authorized by the Institutional
Committee on the Use and Care of Experimental Animals
of Universidad Maimonides, Argentina. Handling and
sacriﬁce of animals were performed in accordance with all
local, state, and federal guidelines for the care and utilization
of laboratory animals. Husbandry of the animals met the
National Institutes of Health Guidelines for the Care and
Use of Laboratory Animals [39].
2.3. Immunohistochemistry (IH) and Immunoﬂuorescence
(IF) with Confocal Microscopy. PFA-ﬁxed ovary and anterior
pituitary of each animal were dehydrated through a graded
series of ethanol and embedded in paraﬃn. Each gland was
sectioned at 5μm thick and mounted onto coated slides. To
analyze pituitary PRL immunoreactivity, 3 slides with 3
adenohypophyseal sections per slide corresponding to rostral
end, medial, and caudal end regions were tested (5 animals
per experimental group). Three distinct adenohypophyseal
ﬁelds at each section were analyzed avoiding superposition
among them. For each ovarian marker (PRLR, LHR, and
3β-HSD), 3 slides (containing 3 tissue sections per slide) cor-
responding to anterior, middle, and posterior regions of the
ovary were tested and the immunoreactivity was analyzed
in all the corpora lutea. Adjacent slides were tested for each
marker (5 animals per experimental group). Brieﬂy, sections
were subjected to antigen retrieval by boiling sections in
10mM sodium citrate buﬀer pH6.0 for 20min. Endogenous
peroxidase activity was quenched, and nonspeciﬁc binding
sites for immunoglobulins were blocked by incubating
sections with 10% normal serum. Immunoreactivity was
detected by incubating sections overnight in a humid
chamber at 4°C with the primary antibody (Table 1,
supplementary material). Speciﬁcity of primary antibodies
was corroborated in adjacent sections by omission of the
primary antibodies.
Immunoreactivity was revealed with a biotinylated goat
anti-rabbit IgG or rabbit anti-goat IgG, as appropriated,
followed by incubation with avidin-biotin complex (ABC
Vectastain Elite kit, Vector Laboratories, Burlingame, USA).
The reaction was visualized with 3,3′-diaminobenzidine
(DAB kit, Vector Laboratories, Burlingame, USA). Sections
were counterstained with hematoxylin for morphological
orientation, dehydrated, and mounted. Sections were imaged
using an optic microscope (BX40, Olympus Optical Corpora-
tion, Tokyo, Japan) ﬁtted with a digital camera (390CU 3.2
Mega Pixel CCD Camera, Micrometrics, Spain).
In order to evaluate qualitatively the diﬀerences in the
levels of immunoreactivity of each marker among the exper-
imental groups, an immunohistochemical scoring combining
the percentage of positive cells and the stain intensity was
performed (“−”=negative, “+”=weak, “++”=moderate,
and “+++”= strong reactivity).
For colocalization of PRLR/3β-HSD and of PRLR/LHR,
anti-PRLR-, anti-LHR-, and anti-3β-HSD-speciﬁc antibodies
were employed (Table 1, supplementary material). PRLR/3β-
HSD: antibodies were incubated overnight and revealed with
Alexa-Fluor 488 coupled horse anti-rabbit IgG for anti-PRLR
IgG detection and Alexa-Fluor 555 coupled donkey anti-
mouse IgG for anti-3β-HSD. PRLR/LHR: after an overnight
incubation with anti-PRLR IgG, the tissue sections were
revealed with Alexa-Fluor 555 coupled horse anti-rabbit
IgG and then incubated overnight with anti-LHR IgG and
revealed with Alexa-Fluor 488 coupled horse anti-rabbit
IgG. Both ﬂuorescent-coupled antibodies were purchased at
Invitrogen Corp. (Invitrogen, California, USA) and used at
a 1 : 500 dilution. Finally, slides were mounted with
Table 1: Inclusion criteria for the experimental groups.
Time of
capture
Number of
embryos in
the uterus
Crown-heel length of
foetuses (mm)
Estimated gestational age
(number of days)a
Ovulatory
stigmata
Serum LH
(ng/ml)
Serum P4
(ng/ml)
Early pregnant (EP) April 8–12 10b 25–35 No 0.62± 0.2 5.71± 2.8
Midpregnant (MP) July 1–2 90–115 90–110 Yes 3.20± 0.7 14.52± 3.95
Term pregnant (TP) August 1–2 145–156 144–154 No 1.21± 0.18 0.75± 0.43
Lactating
nonpregnant (LCT)
September — — — No 0.12± 0.1c 0.21± 0.1
Non-ovulating non-
pregnant (NP)
September — — — No 0.02± 0.01c 0.77± 0.4
aAccording to [37]. bSize of implantation sites (mm). cValues below the detection limits of the assay.
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Vectashield (Vector Laboratories, Burlingame, USA). In
order to eliminate any emission crosstalk between the
ﬂuorophores, sequential line scanning (lambda strobing
mode) was used when acquiring the images. Control sections
using each single antibody were also developed and scanned
by the three lasers to verify that emission was detected only in
the speciﬁc single channel. Five animals were tested per group.
2.4. RNA Isolation. For isolation of total RNA, each piece of
tissue (ovaries and pituitary glands) was homogenized with
TRIzol (Invitrogen, California, USA) according to the manu-
facturer’s instructions. RNA concentration was quantiﬁed by
absorption at 260 nm (GeneQuant, Amersham Biosciences,
England). One μg of total RNA was treated with 1μl DNaseI
(Invitrogen, California, USA) in 1μl 10X DNase Reaction
Buﬀer (Invitrogen, California, USA) for 30 minutes at 37°C,
and the reaction was stopped with 1μl EDTA 50mM
(Invitrogen, California, USA) for 10 minutes at 65°C. The
RNA was reverse transcribed into ﬁrst-strand cDNA using
1.5μl random hexamer primers 50μM (Applied Biosystems,
California, USA), 200U reverse transcriptase (RevertAid™
M-MuLV, Fermentas, Massachusetts, USA), 4μl ﬁrst strand
buﬀer 5x (Fermentas, Massachusetts, USA), 2μl dNTP mix-
ture 10mM (Invitrogen, California, USA), and 0.5μl RNase
inhibitor (Ribolock™, Fermentas, Massachusetts, USA), at a
20μl ﬁnal volume reaction. The reverse transcriptase was
omitted in control reactions, where the absence of PCR-
ampliﬁed DNA indicated the isolation of RNA free of
genomic DNA. The reaction was carried out at 72°C for
10 minutes and 42°C for 60 minutes and stopped by heating
at 70°C for 10 minutes. cDNA was stored at −20°C until use.
2.5. Real-Time Semiquantitative Polymerase Chain Reaction
(qPCR). The abundances of pituitary PRL and ovarian PRLR,
LHR, 3ß-HSD, and 20α-HSD transcripts of each experimen-
tal group were determined by qPCR. Gene-speciﬁc primer
sets for PRL, PRLR, 3ß-HSD, and 20α-HSD were customized
(Life Technologies, California, USA), whereas for LHR and
GAPDH, primers already described in the literature were
used. Primer sequences are shown in Supplementary Table 2.
For the analysis of ovarian PRLR gene expression, we
designed speciﬁc primers over highly homologous regions
obtained from the multiple alignments of PRLR mRNA
sequences from several species evolutionarily related to
vizcachas (Cavia porcellus, Chinchilla lanigera, Mus muscu-
lus, Octodon degus, and Homo sapiens) using the Clustal
Omega software (http://www.ebi.ac.uk/Tools/msa/clustalo/).
We successfully ampliﬁed PRLR in the pituitary, mammary
gland, ovary, and liver of vizcachas (not shown), and the
sequencing of ovarian PRLR exhibited an 88% homology with
chinchilla (Chinchilla lanigera); an85%withguineapig (Cavia
porcellus); an 82% with the desert mole rat (Heterocephalus
glaber); a 78% with the Damara mole rat (Fukomys damaren-
sis), the tree shrew (Tupaia chinensis), the ground squirrel
(Ictidomys tridecemlineatus), and the norwegian rat (Rattus
norvegicus); a 77% with mice (Mus musculus) and degu
(Octodon degus); and a 74% with humans.
For PRL primer design, we proceeded in the same fashion
as we did for PRLR, focusing on those highly conserved PRL
mRNA sequences among the evolutionarily related species
mentioned above. PRL primers were tested using cDNA from
diﬀerent vizcachas’ tissues; pituitary and mammary glands
revealed PRL transcription but not the liver nor the ovaries
(not shown). Sequencing the PCR product of pituitary PRL
of L. maximus showed an 88% homology with the PRL
mRNA of the chinchilla; an 86% with the desert mole rat;
an 85% with the Damara mole rat, the guinea pig, and the
degu; a 77% with the wild boar (Sus scrofa); and a 75% with
primates (Gorilla gorilla, Pan troglodytes, andHomo sapiens).
Ampliﬁcation reactions were carried out using the SYBR
Green PCR Master Mix (Applied Biosystems, California,
USA) on a Stratagene MPX500 cycler (Stratagene, California,
USA). After an initial denaturation step (95°C for 10min), 40
cycles of a 2-step ampliﬁcation protocol (95°C for 15 s, 60°C
for 45 s) were completed. Melting curve analysis was
performed to verify the ampliﬁcation speciﬁcity. Relative
quantiﬁcation of gene expression was performed according
to the mathematical model of Pfaﬄ [40]. Brieﬂy, the
expression ratio was determined for each sample by calcu-
lating (Etarget)
ΔCq(target)/(EGAPDH)
ΔCq(GAPDH), where E is
the eﬃciency of the primer set and ΔCq (quantiﬁcation
cycle) is the diﬀerence in the threshold cycle with
ΔCq=Cq (normalization cDNA)−Cq (experimental cDNA). The
ampliﬁcation eﬃciency of each primer set was calculated
from the slope of a standard ampliﬁcation curve of log
(ng cDNA) per reaction versus Cq value (E=10−(1/slope)).
Eﬃciencies of 2.0± 0.1 were considered optimal. Five ani-
mals were tested per experimental group, and each sample
was analyzed in duplicate along with nontemplate controls.
Each target gene expression was normalized to that of
GAPDH. To conﬁrm PRL, PRLR, 3ß-HSD, and 20α-HSD
identities, puriﬁed PCR products (MinElute Gel Extraction
kit, Qiagen, Hilden, Germany) were sequenced with a
3130xl Genetic Analyzer (Applied Biosystems, California,
USA) by the Genomic Unit of the Biotechnology Institute,
Instituto Nacional de Tecnología Agropecuaria (INTA),
Buenos Aires, Argentina.
2.6. Enzyme-Linked Immunosorbent Assay (ELISA) for P4.
Serum P4 level was determined by ELISA using an EIAgen
Progesterone kit (Adaltis S.r.l., Rome, Italy) as previously
described by our laboratory [29]. Brieﬂy, a direct solid phase
enzyme immunoassay detecting a range of 0.18–40.0 ng/ml
(0.48–127.2 nmol/l) was developed. The absorbance of the
solution measured at 450nm was inversely related to the
concentration of P4 in the sample. Calculation of P4 level
was made by reference to a calibration curve. All captured
vizcachas were evaluated, and their P4 levels are depicted
in Table 1.
2.7. Radioimmunoassay (RIA) for LH. Serum LH level was
determined by RIA with kits from the National Hormone
and Pituitary Program, National Institute of Diabetes,
Digestive and Kidney Diseases, USA, as previously described
by our laboratory [36]. Results were expressed in terms of rat
LH standards using the following standards: for LH
iodination: r-LH-I10, reference preparation rat LH-RP-3,
(AFP7187B) and anti-rat LH-S11 (AFPC697071P) [41].
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Assay sensitivity was 0.31 ng/ml. Intra- and interassay
coeﬃcients of variation were 7.2 and 11.4%, respectively.
All captured vizcachas were evaluated (Table 1). Pooled
pituitary homogenates of high LH levels were serially diluted
to prepare a standard curve for the vizcachas, and the
parallelism with the rat standard curve was conﬁrmed, as
previously described [28]. All captured vizcachas were
evaluated, and their P4 levels are depicted in Table 1.
2.8. Statistical Analysis. Values were expressed as the mean
± standard error of the mean. Statistical diﬀerences were
determined by a one-way analysis of variance (ANOVA)
and Newman-Keuls multiple comparison post hoc tests
using Prism 4.0 (GraphPad Software Inc., San Diego,
California, USA). Diﬀerences were considered statistically
signiﬁcant when p < 0 05. A correlation analysis among
PRLR, LHR, and 3-HSD was performed using the nonpara-
metric Kendall rank correlation coeﬃcient [42].
3. Results
3.1. Ovarian Expression of PRLR and LHR.We examined the
expression of PRLR and LHR by immunohistochemistry in
corpora lutea and by qPCR in the whole ovaries of adult
vizcachas throughout the experimental reproductive stages
(Figures 1 and 2). Since the ovaries of the nonpregnant
LLCSLC
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LHR LHR LHR
+ +++ ++
++ +++ −
++ +++
3𝛽-HSD 3𝛽-HSD
−
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PRLR PRLR PRLR
Figure 1: Luteal levels of PRLR, LHR, and 3ß-HSD increased in pregnant-ovulating vizcachas. Representative photomicrographs of luteal
cells in ovary cross sections immunostained for PRLR, LHR, and 3ß-HSD, at early pregnancy (EP), midpregnancy (MP), and term
pregnancy (TP) of vizcachas. Immunoreactivity is shown in brown and nuclei counterstained with hematoxylin. Immunohistochemical
scoring was determined using a 4-point scale: “+”=weak, “++”=moderate, “+++”= strong, and “−”=negative reactivity. LLC: large luteal
cells; SLC: small luteal cells; O: nonovulated oocyte into a secondary corpus luteum. Scale bar represents 25μm.
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groups of this study (LCT and NP) exhibited almost the total
absence of corpora lutea, the luteal immunoreactivity was
analyzed only at the stages of pregnancy.
We detected PRLR immunoexpression throughout the
entire gestation. Such a positive mark had a grainy
appearance and was evidenced in both small and large luteal
cells (Figure 1). PRLR immunoreactivity was weak at the
beginning of pregnancy; it became markedly stronger at
midgestation and decreased again near parturition time.
Some PRLR reactivity was also observed in nuclei at both
mid- and term pregnancies.
Once the speciﬁcity of PRLR-customized primers was
veriﬁed as described in Material and Methods, PRLR mRNA
levels were examined in ovaries of vizcachas throughout
the reproductive stages. Analysis of qPCR data showed a
4-fold rise when transitioning from early pregnancy to
midpregnancy and a marked decline at the end of gesta-
tion (p < 0 05, n = 5 per group) (Figure 2(a)).
We studied ovarian LHR expression as a key marker
of luteinization (Figure 1). We detected LHR-positive
reactivity in luteal cells along the three stages of preg-
nancy. This mark had grainy appearance as well. LHR
exhibited its most intense immunoreactivity during midpreg-
nancy and then fell to almost imperceptible levels in the term
pregnant group.
For the analysis of LHR by qPCR, we used speciﬁc
primers previously validated for vizcachas by Fraunhoﬀer
et al., [37] (Table 2, supplementary material). Ovarian
LHR transcription levels along the reproductive stages of
vizcachas exhibited a quite similar expression pattern
during gestation than that determined by immunohisto-
chemistry in corpora lutea. Ovarian LHR mRNA level
was signiﬁcantly higher at midpregnancy, the reproductive
stage characterized by the pseudoovulatory event (p < 0 05,
n = 5 per group) (Figure 2(b)). At term pregnancy and
during nonpregnant stages (NP and LCT), LHR transcrip-
tion remained low.
3.2. Ovarian Steroidogenic Enzymes 3ß-HSD and 20α-HSD.
In order to examine the expression of both enzymes
involved in P4 metabolism, 3ß-HSD and 20α-HSD, we
ﬁrst customized primers for PCR (Table 2, supplementary
material). We analyzed both ovarian transcripts proﬁles
throughout the reproductive stages of adult female
vizcachas (Figure 3).
At early pregnancy, 3β-HSD ovarian expression was
slightly higher than that of non-ovulating non-pregnant
group, exhibited its highest level at midpregnancy, almost
tripling the values of the early pregnant group, and then, it
drastically dropped to a sixth before parturition (TP). During
lactation, 3β-HSD expression levels did not diﬀer from those
of the previous reproductive stage (p < 0 05, n = 5 per group)
(Figure 3(a)). In addition, luteal 3β-HSD immunohisto-
chemical scoring analysis showed high reactivity during early
pregnancy and midpregnancy but a complete absence at the
end of pregnancy (Figure 1).
Instead, 20α-HSD gene expression remained low during
early pregnancy, almost undetectable at midpregnancy, and
sharply increased 5-fold at the end of gestation (TP). After
parturition and while females were lactating their litters
(LCT), ovarian 20α-HSD expression signiﬁcantly dropped
to levels similar to those recorded before the pseudoovulatory
event. Non-ovulating non-pregnant group showed signiﬁ-
cantly lower levels than midpregnant but higher than the
remaining experimental groups (p < 0 05, n = 5 per group)
(Figure 3(b)).
Given the similarity of the mRNA expression proﬁles,
we performed a correlation analysis of 3ß-HSD, PRLR,
and LHR transcription levels using the nonparametric test
based on a rank correlation known as Kendall’s rank
correlation coeﬃcient or Kendall’s tau coeﬃcient (τ).
The results showed that τ = 1 for all 5 analyzed reproduc-
tive stages (p < 0 05, n = 5) which indicates an identical
correlation among 3ß-HSD, PRLR, and LHR for each
reproductive stage.
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Figure 2: Transcription of ovarian PRLR and LHR sharply increased in pregnant-ovulating vizcachas. qPCR analysis of mRNA abundance in
ovaries revealed that both PRLR (a) and LHR (b) exhibit their highest levels of transcripts at MP. Values expressed as the mean ± SEM.
Signiﬁcant diﬀerences were determined by a one-way ANOVA (p < 0 05, n = 5 per group). Diﬀerent letters indicate signiﬁcant diﬀerences.
GAPDH was used as housekeeping gene. (NP) non-ovulating non-pregnant, (EP) early pregnant, (MP) midpregnant, (TP) term pregnant,
and (LCT) lactating nonpregnant groups.
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3.3. Colocalization of PRLR and 3ß-HSD. Figure 4 depicts the
colocalization of PRLR and 3ß-HSD using double-labeled
immunoﬂuorescence in corpora lutea of representative vizca-
chas throughout gestation. PRLR and 3ß-HSD were observed
in both small and large luteal cells. A qualitative estimation
indicated that the maximum colocalization of PRLR and
3ß-HSD occurred during midpregnancy, and this result is
consistent with what was analyzed for each marker separately
both by immunohistochemistry and by qPCR. Moreover,
PRLR colocalized with LHR as well, throughout the 3
analyzed pregnancy stages, being midpregnancy the stage
depicting maximum expression of both receptors (Figure 5).
3.4. PRL Levels. We attempted to analyze circulating PRL
levels by both radioimmunoassay (RIA) and enzyme-linked
immunosorbent assay (ELISA). Regrettably, neither of these
techniques proved to be successful for PRL serum determina-
tion in vizcachas. Therefore, to have an approximated idea of
the PRL production along the reproductive stages of adult
female vizcachas, we examined its expression in the pituitary
by immunohistochemistry and by qPCR (Figure 6).
We detected PRL immunoexpression in the pituitary
gland pars distalis in all the experimental groups (Figure 6).
Immunoexpression was mainly observed in the cytoplasm
of isolated lactotrophs or lactotropic cells forming follicular
structures. Non-ovulating non-pregnant females showed a
weak reactivity considered as the basal production of PRL
(Figure 6). The immunoexpression of PRL increased in
mid- and term pregnant groups, exhibiting in the latter
the highest reactivity, especially in those lactotropic cells
closest to the capillaries. During lactation, pituitary PRL
immunoexpression decreased to values similar to the basal
production measured in non-ovulating non-pregnant
animals (Figure 6). Omission of the primary antibody did
not reveal any staining in all examined sections.
Once the speciﬁcity of PRL-customized primers was
established (see Material and Methods), we evaluated the
variations of PRL gene transcription in the pituitary gland
of L. maximus among the ﬁve reproductive stages. The
results obtained from qPCR also indicated a sharp rise of
PRL at the end of gestation (TP). However, unlike what
we had measured for the pituitary protein expression by
immunohistochemistry, PRL mRNA levels remained signif-
icantly high during lactation (p < 0 0005, n = 5 per group)
(Figure 6).
4. Discussion
P4 is essential for the development of normal pregnancy, and
inadequate production of this steroid from the corpus luteum
is associated with pregnancy loss ([43] for a review). In the
present work, we showed for the ﬁrst time, a comparative
relation between the expressions of several molecules directly
or indirectly involved in the synthesis and secretion of luteal
P4 throughout the reproductive cycle of female vizcachas.
Previous reports have shown that Lagostomus maximus
displays a peculiar P4 proﬁle during gestation, which is char-
acterized by two well-deﬁned stages: a ﬁrst wave that begins
to decline after approximately 70 days of pregnancy (d.p.),
reaching a minimum around 100 d.p., and a second increase
at 110–120 d.p., with a ﬁnal decline at parturition time. It is
likely that high levels of P4 in the ﬁrst stage are linked to
the activity of the primary corpora lutea, whereas the increase
during the second stage is largely a result of what is secreted
by the newly formed corpora lutea in the pseudoovulatory
event at the end of the third month of pregnancy [31, 37].
Here, we found that the ovarian PRLR expression proﬁle
and the P4-circulating levels follow a concordant pattern
along the reproductive cycle of adult female vizcachas.
Maximum expression of PRLR recorded at midpregnancy
coincides with the peak of serum P4, while the decrease
of this steroid recorded right before parturition is accompa-
nied by a drastic decrease in both PRLR immunoreactivity
and transcript levels. Moreover, the expression of ovarian
3ß-HSD, the enzyme responsible for the conversion of
pregnenolone in P4, also follows the expression pattern of
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Figure 3: Transcription of ovarian 3ß-HSD and 20α-HSD exhibited opposite patterns during midgestation and term gestation. qPCR analysis
of 3ß-HSDmRNA abundance revealed the highest levels at MP (a) while 20α-HSD transcription remained low (b). Such relation was reversed
at term pregnancy, when 20α-HSD mRNA levels reached its maximum and 3ß-HSD mRNA abundance dropped low close to the recorded
basal values (NP). Values expressed as the mean ± SEM. Signiﬁcant diﬀerences were determined by a one-way ANOVA (p < 0 05, n = 5
per group). Diﬀerent letters indicate signiﬁcant diﬀerences. GAPDH was used as housekeeping gene. (NP) non-ovulating non-pregnant,
(EP) early pregnant, (MP) midpregnant, (TP) term pregnant, and (LCT) lactating nonpregnant groups.
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PRLR throughout the reproductive cycle of L. maximus,
tripling its values when going from early pregnancy to
midpregnancy and dropping them to a sixth at the end of
gestation. Although luteal 3ß-HSD is considered to be con-
stitutively expressed throughout pregnancy, several reports
have shown that 3ß-HSD can be regulated by PRL and
gonadotropins [3, 44, 45].
Our analysis of LHR expression in the ovary of vizcachas
revealed an active transcription level at midpregnancy and in
response to the LH surge. Such an increase followed by an
abrupt fall of LHR mRNA towards the end of pregnancy
could be indicating a receptor desensitization mechanism.
In fact, previous reports have shown that a LHR desensitiza-
tion of luteal cells upon ligand-binding results in a decline in
steady state levels of LHR mRNA [46, 47]. Such loss of LHR
mRNA during receptor downregulation is due to an
increased degradation of the receptor mRNA rather that to
an inhibition of transcription [3, 48].
Activation of LHR in follicular cells by the LH surge
causes ovulation and luteinization. This process alters their
responsiveness to external signals allowing luteal cells to
respond to a new set of hormones, the most important being
PRL and LH [3]. Midpregnant vizcachas exhibited high levels
of transcription for PRLR as well, which could be indicative
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Figure 4: Strongest colocalization of PRLR and 3ß-HSD occurred in luteal cells of pregnant-ovulating vizcachas. Representative confocal
photomicrographs of ovary sections of pregnant vizcachas stained for PRLR (green) and 3ß-HSD (red) using double-labeled
immunoﬂuorescence. Yellow stained represents coexpression of PRLR and 3ß-HSD. Scale score: “+”=weak, “++”=moderate, and “++
+”= strong. Scale bar: 50μm. CL: corpus luteum; FL: follicle; O: nonovulated oocyte into a secondary corpus luteum. EP, MP, and TP
stand for early pregnancy, midpregnancy, and term pregnancy, respectively.
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of a cross talk mechanism between these two hormones for a
coordinated dialogue towards an accurate luteinization pro-
cess in L. maximus as previously documented for mice [22].
It has been shown that the positive regulation of the expres-
sion of LHR during CL formation in conventional rodent
models is modulated by PRL [49–51]. Therefore, it is worth
noting that the Kendall’s τ calculation conﬁrmed a high
correlation between the expression proﬁle of the ovarian
LHR gene and that of PRLR/3β-HSD during vizcacha’s
gestation. This result is in agreement with the high
LHR LHR LHR
PRLR PRLR PRLR
LHR LHR LHR
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Figure 5: Strongest colocalization of PRLR and LHR occurred in luteal cells of pregnant-ovulating vizcachas. Representative confocal
photomicrographs of ovary sections of pregnant vizcachas stained for PRLR (red) and 3ß-HSD (green) using double-labeled
immunoﬂuorescence. Yellow stained represents coexpression of PRLR and LHR. Scale score: “+”=weak, “++”=moderate, and “++
+”= strong. Scale bar: 50μm. CL: corpus luteum; FL: follicle; O: nonovulated oocyte into a secondary corpus luteum. EP, MP, and TP
stand for early pregnancy, midpregnancy, and term pregnancy, respectively.
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colocalization of PRLR with both LHR and 3β-HSD
detected in luteal cells of midgestating animals, which
suggests a possible role of PRL during pseudoovulation
and luteinization of L. maximus.
Interestingly, our data showed that ovarian 20α-HSD, the
enzyme that catalyzes the conversion of P4 into its inactive
form, is repressed during pregnancy of vizcachas, except at
term gestation, when it rises dramatically. Moreover, the
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Figure 6: Pituitary expression of PRL increased during pregnancy. Representative photomicrographs of pituitary gland cross sections of adult
non-ovulating non-pregnant (NP), early pregnant (EP), midpregnant (MP), term pregnant (TP), and lactating non-pregnant (LCT) vizcachas
immunostained for PRL. Immunoreactivity is shown in black (color modiﬁcation of diaminobenzidine precipitation by addition of nickel)
and is highlighted by arrows. “s” indicates a capillary sinusoidal space. Scale score: “+”=weak, “++”=moderate, and “+++”= strong. Scale
bar represents 50μm. Bottom right qPCR analysis of pituitary PRL mRNA abundance revealed that TP group exhibits the highest level of
transcripts. After parturition and while nurturing the litter (LCT), PRL mRNA quantity decreases although is still signiﬁcantly higher than
NP, EP, and MP (p < 0 0005, n = 5 per group, one-way ANOVA). Diﬀerent letters indicate signiﬁcant diﬀerences. GAPDH was used as
housekeeping gene.
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expression of 20α-HSD along gestation contrasted with both
the 3ß-HSD and the PRLR/LHR proﬁles.
There have been several reports showing that ovarian
20α-HSD expression is modulated by PRL. Deﬁcient signal
transducers and activators of transcription (Stats) Stat5a/
Stat5b mice have shown that the impairment of these major
PRL signaling mediators trigger pregnancy loss that cor-
relates with an increased 20α-HSD and a decreased
serum P4 [52]. In addition, PRLR knockout mice exhibit
corpora lutea undergoing regression and insuﬃcient levels
of P4 to support implantation due to the absence of
downregulation of 20α-HSD by PRL [21]. Even more,
administration of P4 in the form of subcutaneous pellets
rescues preimplantation embryo development and implan-
tation in PRLR knockout females [53]. Another interesting
report by Clementi and coworkers [54] also suggests that
the luteotropic eﬀect of the decidual tissue in rats is medi-
ated through the secretion of pituitary PRL, which in turn
stimulates P4 biosynthesis by increasing luteal 3β-HSD
activity, and inhibits P4 catabolism by diminishing luteal
20α-HSD activity.
In the present work, we estimated variation of PRL levels
throughout the reproductive cycle of vizcachas by measuring
pituitary PRL expression by immunohistochemistry and
mRNA levels by qPCR. So far, our attempts to determine
circulating PRL levels either by RIA or by ELISA did not yield
positive results probably due to a subject linked to the
speciﬁcity of the antibodies used in both techniques. PRL
immunodetection was evidenced in the cytoplasm of
lactotropic cells localized in the pars distalis as previously
described by Filippa and Mohamed [55]. During gestation,
particularly from midpregnancy, we detected a signiﬁcant
accumulation of pituitary PRL that reached its maximum
at term pregnancy. The rate of PRL transcription increased
along pregnancy as well. PRL drives the process of lacta-
tion, and thus it would be expected to ﬁnd at this stage
the highest level of this hormone in the pituitary gland.
Yet, we measured a marked decrease of PRL immunoreac-
tivity in pituitary of lactating compared to term-pregnant
females. A possible explanation of this decrement would
be that, during lactation, the constant demand exerted by
the litter through the stimulus of suckling may cause the
newly synthesized hormone to be immediately poured into
the circulatory system, preventing its accumulation into
the lactotrophs.
The pituitary PRL proﬁle here characterized clearly has a
diﬀerent pattern than its ovarian receptor. However, it must
be considered that mammary glands are the primary target
of PRL. In fact, pituitary PRL expression determined in this
study is in agreement with the documented increased expres-
sion of PRLR in mammary glands of vizcachas throughout
gestation and this is tightly related to the mammary gland
preparation for the eventual nurturing of the forthcoming
oﬀspring [29, 38, 56].
In short, if the luteal steroidogenesis of pregnant
vizcachas is, as we hypothesized, modulated in part by PRL,
our results suggest that such regulation would be driven by
the diﬀerent levels of PRLR expressed in the ovaries at each
stage of pregnancy.
This is the ﬁrst attempt to relate PRL as well as its ovarian
receptor to some key steroidogenic markers involved in the
production of P4 during gestation of vizcachas. Notwith-
standing the present investigation is a static study and there-
fore a causal relationship between PRLR/LHR increased
expression and the increment in P4 levels cannot be ascer-
tained, it is an interesting start point to inquire into the
mechanisms that drive luteal steroidogenesis in L. maximus.
This takes special relevance if we consider that for other
rodents such as mice and rats, PRLR is a key component
regulating ovarian function and governing the regulation of
P4 secretion [2, 23, 57].
In summary, the results of our investigation showed
that the maximal expression recorded for PRLR, LHR,
and 3β-HSD occurs at midpregnancy, when the pseu-
doovulatory event occurs, and coincides with both a
minimal 20α-HSD expression and a marked increase in
P4 serum levels. Instead, the period of time preceding
parturition is characterized by 20α-HSD in its highest
level of expression, which contrasts with the minimum
of PRLR/LHR/3β-HSD and with the lowest levels of
circulating P4. The expression patterns of these two
steroidogenic enzymes suggest that PRL and LH through
its ovarian receptors would indirectly favor luteal P4
production in early and midpregnant vizcachas by both
stimulating 3β-HSD and by negatively modulating 20α-
HSD, whereas such modulation would invert at the
end of pregnancy allowing the fall of P4 that ultimately
elicits parturition in L. maximus. Our results suggest an
active role of PRL as an LH partner in the modulation
of luteal steroidogenesis and P4 production throughout
gestation of vizcachas.
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